According to the CDC, Lyme disease affects 329,000 people in the U.S. each year and can cause severe damage to joints and the neurologic system. The CDC recently linked Lyme disease with several deaths due to cardiac disease caused by Borrelia. The problem is spreading, and “Lyme disease–carrying ticks are now in half of all U.S. counties” (Science, 2016).
Lyme Disease Progression in the United States
Source: Science, 2016
US BIOLOGIC uses a One Health approach guided by predictive analytics to focus on the point of disease transmission, which are the interactions between mice and ticks. The solution, then, is simple: inoculate the mouse with a vaccine and stop the transmission cycle.
According to a study published in the Journal of Infectious Diseases (abstract), the authors demonstrated that the vaccine pellet technology reduced the prevalence of infected ticks by 76% in field conditions.
The authors state: “Implementation of such a long-term public health measure could substantially reduce the risk of human exposure to Lyme disease.”
This vaccine pellet approach could be complemented by an integrated tick management program that includes mouse-reduction and tick-reduction programs, such as those successfully employed by pest-management professionals.
Mice find the pellets through the LymeShield® timed-application release station.
The LymeShield Station holds the pellets securely in six separate chambers. Every few weeks, a new chamber opens, and mice in the area have access to the eco-friendly pellets.
Nothing. The LymeShield Station, once loaded by a pest-management professional, functions on its own and requires a refill of pellets only once a quarter for year-long coverage.
To learn more about ticks and tick-borne disease, visit our Tick News page for related articles.
To contact US BIOLOGIC, please email us at email@example.com.